Potensi Kombinasi Terapi Sel Punca Mesenkimal dengan Obat Antifibrotik sebagai Tata Laksana Fibrosis Paru Pasca COVID-19
Background: COVID-19 has infected more than 88 million people worldwide. Researchers found that over one-third of patients who survived showed lung abnormalities related to pulmonary fibrosis post COVID-19. PF is a progressive disease responsible for reducing pulmonary function which ultimately caus...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Talenta Publisher
2022-02-01
|
| Series: | Scripta Score Scientific Medical Journal |
| Subjects: | |
| Online Access: | https://talenta.usu.ac.id/scripta/article/view/5390 |